Injectable anti-cancer drug loaded silk-based hydrogel for the prevention of cancer recurrence and post-lumpectomy tissue regeneration aiding triple-negative breast cancer therapy
Authors:
- 5 December 2022
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 145, 213224
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation
- Department of Biotechnology
- Department of Science and Technology
This publication has 77 references indexed in Scilit:
- Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two DecadesJournal of Breast Cancer, 2012
- Silk fibroin as a vehicle for drug delivery applicationsJournal of Controlled Release, 2011
- Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogelJournal of Drug Targeting, 2010
- Encapsulation of adipogenic factors to promote differentiation of adipose-derived stem cellsJournal of Drug Targeting, 2009
- A novel method for dissolution and stabilization of non‐mulberry silk gland protein fibroin using anionic surfactant sodium dodecyl sulfateBiotechnology and Bioengineering, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic modelBiomaterials, 2007
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast CancerNew England Journal of Medicine, 1996